Novartis Media Relations E-mail: [email protected] Novartis Investor Relations Central investor relations line: +41 61 ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Majority of Participants Reached a Defined Threshold for Remission of Tardive Dyskinesia Regardless of Underlying Psychiatric Disorder <l ...

More recent case law has reinforced this principle, holding that when therapeutic and non-therapeutic effects are inseparably ...

Dr. Deep Dutta, an endocrinologist, countered the myth that eggs raise cholesterol, stating his own experience eating 28 eggs ...

U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and weighing ...

Daiichi Sankyo launches Datroway in Japan for patients with previously treated unresectable or recurrent HR positive, HER2 negative breast cancer: Tokyo Thursday, March 20, 2025, ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Metagenomi (NASDAQ:MGX – Get Free Report) had its price objective lowered by stock analysts at Wells Fargo & Company from $25 ...

Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to robust long-term clinical responses and was well tolerated ...

New breakthrough promises near-perfect EV battery recycling Budget-friendly BYD Dolphin Surf is coming to Europe with a sub-$25,000 price tag MG revamps its MG4 best-seller ...

New breakthrough promises near-perfect EV battery recycling Budget-friendly BYD Dolphin Surf is coming to Europe with a sub-$25,000 price tag MG revamps its MG4 best-seller ...